PReSTaR
acts as an international academic research service to the paediatric rheumatology community for the
implementation of
non-profit trials, disease registries and
other research
initiatives led by investigators
(consensus conferences, cross-cultural adaptations of
questionnaires, research training and courses).
Currently, PReSTaR is coordinating the following projects:
Ongoing
This study is an open-label, randomized, multicenter trial that incorporates a multi-arm design comparing each of 3 non-TNFi (Tumor Necrosis Factor inhibitor) medications to a second TNFi (active control)...
Ongoing
Retrospective-prospective, observational, descriptive and multicenter study of patients with KD for the comparison and performance of Kobayashi and Kawanet IVIg resistance scores in a multi-centric European and North Indian cohort of Kawasaki disease.
Ongoing
The DAISY study (Applicability of standardized ultrasound examination to estimate disease activity in combination with JADAS and inflammation markers in JIA patients) aims to investigate sensitivity and predictive value of the multi-biomarker panel and to evaluate if it could be applied in limited number of joints in patients with oligo and polyarticular JIA course as a new disease activity tool and outcome measure.
Ongoing
A joined PReS, ESID, ISSAID, ERN-RITA and PRINTO network’s effort has been started with the aim to buid a registry of children and young adults who have developed serious inflammatory condition in temporal association with COVID-19 in the community.
Ongoing
Eurofever Project
The PReS Autoinflammatory Diseases’ Working Group, in collaboration with PRINTO, set up a a web-based international registry for Autoinflammatory diseases.
PReSTaR is committed to continuously expanding its research activities. We are currently planning innovative new clinical studies in the following areas:
Are you a center interested in participating in our future studies or do you have ideas for collaborations? Contact us to explore potential research partnerships.